Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 273 articles:
HTML format
Text format



Single Articles


    May 2018
  1. HE H, Li W, Yan P, Bundschuh R, et al
    Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
    Thyroid. 2018 May 16. doi: 10.1089/thy.2017.0258.
    PubMed     Text format     Abstract available


  2. CHU KP, Baker SP, Zenke JK, Morad A, et al
    Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease Recurrence.
    Thyroid. 2018 May 10. doi: 10.1089/thy.2017.0136.
    PubMed     Text format     Abstract available


  3. CABANILLAS M, Ferrarotto R, Garden A, Ahmed S, et al
    Neoadjuvant BRAF- and immune- directed therapy for anaplastic thyroid carcinoma.
    Thyroid. 2018 May 10. doi: 10.1089/thy.2018.0060.
    PubMed     Text format     Abstract available



  4. Correction to: Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study, by Kim M, Kim TH, Shin DY, Lim DJ, Kim EY, Kim WB, Chung JH, Shong YK, Kim BH, an
    Thyroid. 2018;28:686.
    PubMed     Text format    


    March 2018
  5. ROSARIO PW
    Re: "A Follow-Up Strategy for Patients with Excellent Response to Initial Therapy for Differentiated Thyroid Carcinoma" by Jeon et al. (Thyroid 2018;28:187-192).
    Thyroid. 2018 Mar 27. doi: 10.1089/thy.2017.0644.
    PubMed     Text format    


    February 2018
  6. LEI J, Zhong J, Li Z, Wei T, et al
    A nomogram based on the characteristics of metastatic lymph nodes to predict papillary thyroid carcinoma recurrence.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0422.
    PubMed     Text format     Abstract available


  7. KIM M, Jeon M, Oh HS, Park S, et al
    <i>BRAF</i> and <i>RAS</i> mutational status in non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive subtype of encapsulated follicular variant of papillary thyroid carcinoma in Korea.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0382.
    PubMed     Text format     Abstract available


  8. HIRSCH D, Twito O, Levy S, Bachar G, et al
    Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma - An Israeli Multicenter Study.
    Thyroid. 2018 Feb 5. doi: 10.1089/thy.2017.0371.
    PubMed     Text format     Abstract available


    January 2018
  9. LUBITZ CC, Zhan T, Gunda V, Amin S, et al
    Circulating BRAFV600E levels correlate with treatment in patients with thyroid carcinoma.
    Thyroid. 2018 Jan 29. doi: 10.1089/thy.2017.0322.
    PubMed     Text format     Abstract available


  10. JAHANBANI I, Al-Abdallah A, Ali R, Al-Brahim N, et al
    Discriminatory miRNAs for the management of papillary thyroid carcinoma and noninvasive follicular thyroid neoplasms with papillary-like nuclear features.
    Thyroid. 2018 Jan 29. doi: 10.1089/thy.2017.0127.
    PubMed     Text format     Abstract available


  11. KIM M, Kim TH, Shin DY, Lim DJ, et al
    Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study.
    Thyroid. 2018 Jan 19. doi: 10.1089/thy.2017.0356.
    PubMed     Text format     Abstract available


  12. OH HS, Kwon H, Song E, Jeon M, et al
    Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Thyroid. 2018 Jan 19. doi: 10.1089/thy.2017.0514.
    PubMed     Text format     Abstract available


  13. KIM MJ, Won JK, Jung KC, Kim JH, et al
    Clinical characteristics of subtypes of follicular variant papillary thyroid carcinoma.
    Thyroid. 2018 Jan 17. doi: 10.1089/thy.2016.0671.
    PubMed     Text format     Abstract available


  14. CARVALHO M, Rosario PW, Mourao GF, Oliveira LFF, et al
    Clinical impact of detectable antithyroglobulin antibodies below the reference limit (borderline) in patients with papillary thyroid carcinoma with negative serum thyroglobulin and neck ultrasonography after ablation: a prospective study.
    Thyroid. 2018 Jan 12. doi: 10.1089/thy.2017.0350.
    PubMed     Text format     Abstract available


    November 2017
  15. JEON M, Kim M, Park S, Oh HS, et al
    A follow-up strategy for patients with excellent response to initial therapy for differentiated thyroid carcinoma : less is better.
    Thyroid. 2017 Nov 27. doi: 10.1089/thy.2017.0130.
    PubMed     Text format     Abstract available


  16. WATUTANTRIGE-FERNANDO S, Vianello F, Barollo S, Bertazza L, et al
    The Hobnail variant of Papillary Thyroid Carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes.
    Thyroid. 2017 Nov 27. doi: 10.1089/thy.2017.0248.
    PubMed     Text format     Abstract available


  17. IYER P, Dadu R, Ferrarotto R, Busaidy N, et al
    Real world experience with targeted therapy for the treatment of anaplastic thyroid carcinoma.
    Thyroid. 2017 Nov 22. doi: 10.1089/thy.2017.0285.
    PubMed     Text format     Abstract available


  18. KLEIN HESSELINK MS, Bocca G, Hummel YM, Brouwers AH, et al
    Diastolic dysfunction is common in survivors of pediatric differentiated thyroid carcinoma.
    Thyroid. 2017 Nov 13. doi: 10.1089/thy.2017.0383.
    PubMed     Text format     Abstract available


  19. NAM SH, Roh JL, Gong G, Cho KJ, et al
    Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
    Thyroid. 2017 Nov 8. doi: 10.1089/thy.2017.0334.
    PubMed     Text format     Abstract available


  20. KUO EJ, Thi WJ, Zheng F, Zanocco K, et al
    Individualizing surgery in papillary thyroid carcinoma based on a detailed sonographic assessment of extrathyroidal extension.
    Thyroid. 2017 Nov 7. doi: 10.1089/thy.2017.0457.
    PubMed     Text format     Abstract available


    October 2017
  21. SCHMOHL KA, Dolp P, Schug C, Knoop K, et al
    Reintroducing the sodium iodide symporter (NIS) to anaplastic thyroid carcinoma.
    Thyroid. 2017 Oct 15. doi: 10.1089/thy.2017.0290.
    PubMed     Text format     Abstract available


    September 2017
  22. CANO JM, Galan R, Lopez R
    Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged Treatment with Somatostatin Analogues.
    Thyroid. 2017.
    PubMed     Text format     Abstract available


  23. YAPA S, Mulla O, Green V, England J, et al
    The Role of Chemokines in Thyroid Carcinoma.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2016.0660.
    PubMed     Text format     Abstract available


  24. RUIZ-FERRER M, Fernandez RM, Navarro E, Antinolo G, et al
    <i>ESR2</i> gene and Medullary Thyroid Carcinoma.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2017.0171.
    PubMed     Text format     Abstract available


    August 2017
  25. CHINN SB, Zafereo M, Waguespack SG, Edeiken BS, et al
    Long-term outcomes of lateral neck dissection in patients with recurrent or persistent well-differentiated thyroid cancer.
    Thyroid. 2017 Aug 15. doi: 10.1089/thy.2017.0203.
    PubMed     Text format     Abstract available


    July 2017
  26. HAHN SY, Shin JH, Oh YL, Kim TH, et al
    Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2016.0677.
    PubMed     Text format     Abstract available


    June 2017
  27. TANG AL, Falciglia M, Yang H, Mark JR, et al
    Validation of ATA Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine Needle Aspiration.
    Thyroid. 2017 Jun 28. doi: 10.1089/thy.2016.0555.
    PubMed     Text format     Abstract available


  28. KLUBO-GWIEZDZINSKA J, Yang LA, Merkel R, Patel D, et al
    Results of screening in familial nonmedullary thyroid cancer.
    Thyroid. 2017 Jun 28. doi: 10.1089/thy.2016.0668.
    PubMed     Text format     Abstract available


  29. ITO Y, Onoda N, Ito KI, Sugitani I, et al
    Sorafenib in Japanese Patients With Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
    Thyroid. 2017 Jun 21. doi: 10.1089/thy.2016.0621.
    PubMed     Text format     Abstract available


  30. SILVA-VIEIRA M, Carrilho-Vaz S, Esteves S, C Ferreira T, et al
    Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
    Thyroid. 2017 Jun 14. doi: 10.1089/thy.2016.0655.
    PubMed     Text format     Abstract available


  31. PILLI T, Cantara S, Marzocchi C, Cardinale S, et al
    Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients.
    Thyroid. 2017 Jun 12. doi: 10.1089/thy.2017.0035.
    PubMed     Text format     Abstract available


    May 2017
  32. GONZALEZ HE, Martinez JR, Vargas S, Solar A, et al
    A 10-gene classifier for indeterminate thyroid nodules: Development and multicenter accuracy study.
    Thyroid. 2017 May 18. doi: 10.1089/thy.2017.0067.
    PubMed     Text format     Abstract available


  33. POLE JD, Zuk AM, Wasserman JD
    Diagnostic and Treatment Patterns among Children, Adolescents and Young Adults with Thyroid Cancer in Ontario: 1992-2010.
    Thyroid. 2017 May 17. doi: 10.1089/thy.2016.0629.
    PubMed     Text format     Abstract available


  34. RANDLE RW, Bushman NM, Orne J, Balentine CJ, et al
    PAPILLARY THYROID CANCER: THE GOOD AND BAD OF THE "GOOD CANCER".
    Thyroid. 2017 May 16. doi: 10.1089/thy.2016.0632.
    PubMed     Text format     Abstract available


  35. WILSON L, Huang W, Chen L, Ting J, et al
    Cost-Effectiveness of Lenvatinib, Sorafenib, and Placebo in the Treatment of Radioiodine Refractory Differentiated Thyroid Cancer.
    Thyroid. 2017 May 9. doi: 10.1089/thy.2016.0572.
    PubMed     Text format     Abstract available


  36. HEDMAN C, Djarv T, Strang P, Lundgren CI, et al
    The effect of thyroid-related symptoms on long-term quality of life in patients with differentiated thyroid carcinoma - a population-based study in Sweden.
    Thyroid. 2017 May 5. doi: 10.1089/thy.2016.0604.
    PubMed     Text format     Abstract available


  37. INIGUEZ ARIZA NM, Ryder M, Hilger CR, Bible KC, et al
    Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.
    Thyroid. 2017 May 4. doi: 10.1089/thy.2016.0627.
    PubMed     Text format     Abstract available


  38. KIM M, Kim WG, Park S, Kwon H, et al
    Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma.
    Thyroid. 2017 May 2. doi: 10.1089/thy.2016.0676.
    PubMed     Text format     Abstract available


  39. HONG MJ, Na DG, Baek JH, Sung JY, et al
    Cytology-Ultrasonography (CU) Risk Stratification Scoring System Based on Fine-needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System (K-TIRADS).
    Thyroid. 2017 May 2. doi: 10.1089/thy.2016.0603.
    PubMed     Text format     Abstract available


  40. CHUNG SR, Baek JH, Park HS, Choi YJ, et al
    Ultrasound-Pathology Discordant Nodules on Core-Needle Biopsy: Malignancy Risk and Management Strategy.
    Thyroid. 2017;27:707-713.
    PubMed     Text format     Abstract available


    April 2017
  41. RUBIO GA, Koru-Sengul T, Vaghaiwalla TM, Parikh PP, et al
    Postoperative Outcomes in Graves' Disease Patients: Results from the Nationwide Inpatient Sample Database.
    Thyroid. 2017 Apr 29. doi: 10.1089/thy.2016.0500.
    PubMed     Text format     Abstract available


  42. OH HS, Kim WG, Park S, Kim M, et al
    Serial neck ultrasonographic evaluation of changes in papillary thyroid carcinoma during pregnancy.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0618.
    PubMed     Text format     Abstract available


  43. KIM H, Kim TH, Choe JH, Kim JH, et al
    Patterns of initial recurrence in completely resected papillary thyroid carcinoma.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0648.
    PubMed     Text format     Abstract available


  44. YANG Z, Flores J, Katz S, Nathan CA, et al
    Comparison of survival outcomes following post-surgical radioactive iodine versus external beam radiation in stage IV differentiated thyroid carcinoma.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0650.
    PubMed     Text format     Abstract available


  45. MA C, Feng F, Wang S, Fu H, et al
    Chinese data of efficacy of low- and high-dose of iodine-131 for the ablation of thyroid remnant.
    Thyroid. 2017 Apr 12. doi: 10.1089/thy.2015.0658.
    PubMed     Text format     Abstract available


  46. PAULSON VA, Shivdasani P, Angell TE, Cibas ES, et al
    Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Thyroid. 2017;27:506-511.
    PubMed     Text format     Abstract available


  47. MUJAMMAMI M, Tamilia M
    Response to Tulchinsky and Avram re: "Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine".
    Thyroid. 2017;27:592.
    PubMed     Text format    


    March 2017
  48. IYAMA K, Matsuse M, Mitsutake N, Rogounovitch T, et al
    Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET in Thyroid Cancers of Young Patients in Fukushima.
    Thyroid. 2017 Mar 29. doi: 10.1089/thy.2016.0673.
    PubMed     Text format     Abstract available


  49. BONHOMME B, Godbert Y, Perot G, Alghuzlan A, et al
    Molecular pathology of anaplastic thyroid carcinomas: a retrospective study of 144 cases.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0254.
    PubMed     Text format     Abstract available


  50. TAVARELLI M, Sarfati J, Chereau N, Tissier F, et al
    Heterogeneous prognoses for pT3 papillary thyroid carcinomas and impact of delayed risk stratification.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0512.
    PubMed     Text format     Abstract available


  51. IZKHAKOV E, Barchana M, Liphshiz I, Silverman B, et al
    Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
    Thyroid. 2017 Mar 24. doi: 10.1089/thy.2016.0481.
    PubMed     Text format     Abstract available


  52. LANG BH, Woo YC, Chiu KW
    Single-Session High-Intensity Focused Ultrasound Treatment in Large-Sized Benign Thyroid Nodules.
    Thyroid. 2017 Mar 22. doi: 10.1089/thy.2016.0664.
    PubMed     Text format     Abstract available


  53. NICKEL B, Brito JP, Barratt A, Jordan S, et al
    Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.
    Thyroid. 2017 Mar 21. doi: 10.1089/thy.2016.0483.
    PubMed     Text format     Abstract available


  54. LEE SE, Hwang TS, Choi YL, Kim WY, et al
    Molecular profiling of papillary thyroid carcinoma in Korea with high prevalence of BRAF V600E mutation.
    Thyroid. 2017 Mar 15. doi: 10.1089/thy.2016.0547.
    PubMed     Text format     Abstract available


  55. CIPRIANI NA, Agarwal S, Dias-Santagata D, Faquin WC, et al
    Clear cell change in thyroid carcinoma: a clinicopathologic and molecular study with identification of variable genetic anomalies.
    Thyroid. 2017 Mar 15. doi: 10.1089/thy.2016.0631.
    PubMed     Text format     Abstract available


  56. SHAH SA, Adam MA, Thomas S, Scheri RP, et al
    Racial Disparities In Differentiated Thyroid Cancer: Have We Bridged The Gap?
    Thyroid. 2017 Mar 15. doi: 10.1089/thy.2016.0626.
    PubMed     Text format     Abstract available


  57. ZANELLA AB, Scheffel RS, Pasa M, Dora JM, et al
    The Role of Postoperative Stimulated Thyroglobulin as Prognostic Factor for Differentiated Thyroid Cancer in Children and Adolescents.
    Thyroid. 2017 Mar 14. doi: 10.1089/thy.2016.0559.
    PubMed     Text format     Abstract available


    February 2017
  58. MOON S, Song YS, Kim YA, Lim JA, et al
    Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis.
    Thyroid. 2017 Feb 9. doi: 10.1089/thy.2016.0350.
    PubMed     Text format     Abstract available


    January 2017
  59. XU B, Tallini G, Scognamiglio T, Roman BR, et al
    Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    Thyroid. 2017 Jan 30. doi: 10.1089/thy.2016.0649.
    PubMed     Text format     Abstract available


  60. MURATA T, Iwadate M, Takizawa Y, Miyakoshi M, et al
    An adult mouse thyroid side population cell line that exhibits enriched epithelial-to-mesenchymal transition.
    Thyroid. 2017 Jan 27. doi: 10.1089/thy.2016.0130.
    PubMed     Text format     Abstract available


  61. GRIFFIN A, Brito JP, Bahl M, Hoang JK, et al
    Applying criteria of active surveillance to low-risk thyroid papillary cancer over a decade: How many surgeries and complications can be avoided?
    Thyroid. 2017 Jan 26. doi: 10.1089/thy.2016.0568.
    PubMed     Text format     Abstract available


  62. HAUGEN BR MD, Sawka AM, Alexander EK, Bible KC, et al
    The ATA Guidelines on Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of eFVPTC without Invasion to NIFTP.
    Thyroid. 2017 Jan 23. doi: 10.1089/thy.2016.0628.
    PubMed     Text format     Abstract available


  63. CHOI YJ, Baek JH, Park HS, Shim WH, et al
    A computer-aided diagnosis system using artificial intelligence for the diagnosis and characterization of thyroid nodules on ultrasound: initial clinical assessment.
    Thyroid. 2017 Jan 10. doi: 10.1089/thy.2016.0372.
    PubMed     Text format     Abstract available


  64. ESZLINGER M, Bohme K, Ullmann M, Gorke F, et al
    Evaluation of a two-year routine application of molecular testing of thyroid fine needle aspirations (FNA) using a 7-gene-panel in a primary referral setting in Germany.
    Thyroid. 2017 Jan 10. doi: 10.1089/thy.2016.0445.
    PubMed     Text format     Abstract available


  65. PAEPEGAEY AC, Cochand-Priollet B, Louiset E, Sarfati PO, et al
    Long-term control of hypercortisolism by vandetanib in a medullary thyroid carcinoma with a somatic RET mutation.
    Thyroid. 2017 Jan 9. doi: 10.1089/thy.2016.0334.
    PubMed     Text format     Abstract available


  66. RAO SN, Zafereo M, Dadu R, Busaidy N, et al
    Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.
    Thyroid. 2017 Jan 9. doi: 10.1089/thy.2016.0395.
    PubMed     Text format     Abstract available


  67. ALEXANDER EK, Pearce EN, Brent GA, Brown RS, et al
    2016 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum.
    Thyroid. 2017 Jan 6. doi: 10.1089/thy.2016.0457.
    PubMed     Text format     Abstract available


  68. ITO M, Miyauchi A, Fujiwara M, Yoshioka W, et al
    Biochemical markers reflecting thyroid function in athyreotic patients on levothyroxine monotherapy.
    Thyroid. 2017 Jan 5. doi: 10.1089/thy.2016.0426.
    PubMed     Text format     Abstract available


  69. CAVALLO A, Johnson DN, White MG, Siddiqui S, et al
    Thyroid nodule size at ultrasound as a predictor of malignancy and final pathologic size.
    Thyroid. 2017 Jan 4. doi: 10.1089/thy.2016.0336.
    PubMed     Text format     Abstract available


  70. VAN DER WARDT RA, Persoon AC, Klein Hesselink EN, Links TP, et al
    Long-term follow-up for differentiated thyroid carcinoma patients - a reconsideration.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0314.
    PubMed     Text format     Abstract available


  71. XU B, Tuttle RM Md, Sabra M, Ganly I, et al
    Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinico-Pathologic and Molecular Characteristics.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0582.
    PubMed     Text format     Abstract available


  72. AZMAT U, Porter K, Senter L, Ringel MD, et al
    Thyroglobulin Liquid Chromatography-Tandem Mass Spectrometry Has a Low Sensitivity for Detecting Structural Disease in Patients with Antithyroglobulin Antibodies.
    Thyroid. 2017;27:74-80.
    PubMed     Text format     Abstract available


    December 2016
  73. SHEN FC, Hsieh CJ, Huang IC, Chang YH, et al
    Dynamic risk estimates of outcome in Chinese patients with well-differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation.
    Thyroid. 2016 Dec 22. doi: 10.1089/thy.2016.0479.
    PubMed     Text format     Abstract available


  74. HAYMART MR, Pearce EN
    How Much Should Thyroid Cancer Impact Plans for Pregnancy?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    November 2016
  75. PARK S, Kim WG, Song E, Oh HS, et al
    Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated without Radioactive Iodine Remnant Ablation Therapy.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  76. SHAHA MA, Wang LY, Migliacci JC, Palmer FL, et al
    Previous external beam radiation treatment exposure does not confer worse outcome for patients with differentiated thyroid cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  77. CORDIOLI MI, Moraes L, Bastos AU, Besson P, et al
    Fusion oncogenes are the main genetic events found in sporadic papillary thyroid carcinomas from children.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  78. RAKHLIN L, Fish S, Tuttle RM Md
    Response to therapy status is an excellent predictor of pregnancy-associated structural disease progression in patients previously treated for differentiated thyroid cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  79. LUBITZ CC, De Gregorio L, Fingeret AL, Economopoulos KP, et al
    Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  80. NIKITSKI A, Rogounovitch T, Bychkov A, Takahashi M, et al
    Genotype analyses in the Japanese and Belarusian populations reveal independent effects of rs965513 and rs1867277 but do not support the role of FOXE1 polyalanine tract length in conferring risk for papillary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  81. JI Q, Shi R, Qu N, Luo T, et al
    Programmed death-ligand 1 expression in papillary thyroid cancer and its correlation with clinicopathological factors and recurrence.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  82. ALZAHRANI AS, Murugan AK, Qasem E, Alswailem M, et al
    Single Point Mutations in Pediatric Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  83. RAGO T, Scutari M, Loiacono V, Santini F, et al
    Low elasticity of thyroid nodules at ultrasound elastography is correlated with malignancy, degree of fibrosis and high expression of galectin-3 and fibronectin-1.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    October 2016
  84. WEINBERGER P, Ponny SR, Xu H, Bai S, et al
    Cell Cycle M-phase Genes are Highly Upregulated in Anaplastic Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  85. CASTELBLANCO E, Zafon C, Maravall J, Gallel P, et al
    APLP2, RRM2 and PRC1: new putative markers for the differential diagnosis of thyroid follicular lesions.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  86. SANDULACHE VC, Williams MD, Lai SY, Lu C, et al
    Real-time genomic characterization utilizing circulating cell-free DNA in patients with anaplastic thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  87. RABINOWITS G, Barletta J, Sholl LM, Reche E, et al
    Successful Management of a Patient with Malignant Thyroid Teratoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  88. JEONG HS, Choi EK, Song IU, Chung YA, et al
    Differences in brain glucose metabolism during preparation for I-131 ablation in thyroid cancer patients: Thyroid hormone withdrawal versus recombinant human thyrotropin.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  89. KIM SK, Park I, Hur N, Lee JH, et al
    Should Level V Be Routinely Dissected in N1b Papillary Thyroid Carcinoma?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  90. CORREA NL, de Sa LV, Corbo R
    Estimation of second primary cancer risk after treatment with radioactive iodine for differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  91. MERTEN MM, Castro MR, Zhang J, Durski JM, et al
    Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography (PET/CT) in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  92. WANG Q, Yang H, Wu L, Yao J, et al
    Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathological Characteristics and BRAF-mutation in Papillary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  93. BHALLA S, Monga D, Soni T, Gaurang A, et al
    Competency Education of Primary Care Physicians in Management of Thyroid Disorders: Implementation Experiences from a Pan India Certificate Course.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  94. LANG BH, Shek T, Chan AO, Lo CY, et al
    Significance of size of persistent/recurrent central nodal disease on surgical morbidity and response to therapy in reoperative neck dissection for papillary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  95. KIM SK, Park I, Woo JW, Lee JH, et al
    Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size < 4 cm.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  96. KIM M, Kim WG, Park S, Kwon H, et al
    The Initial Size of Metastatic Lesions is the Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  97. ROSSING RM, Jentzen W, Nagarajah J, Bockisch A, et al
    Serum thyroglobulin doubling time in progressive thyroid cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  98. LEE SG, Lee WK, Lee HS, Moon J, et al
    Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  99. GAVRILA A, Hasselgren PO, Glasgow A, Doyle AN, et al
    Variable Cold-induced Brown Adipose Tissue Response to Thyroid Hormone Status.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  100. NAJAFIAN A, Noureldine SI, Azar F, Atallah C, et al
    RAS Mutations, RET/PTC and PAX8/PPAR-gamma Chromosomal Rearrangements Are Also Prevalent in Benign Thyroid Lesions? Implications Thereof and, A Systematic Review.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  101. TULCHINSKY M, Avram A
    Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine: Patient Cohort Definition Makes No Sense.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  102. HONG S, Yu S, Li J, Yin Y, et al
    MiR-20b Displays Tumor Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    September 2016
  103. XU JY, Grubbs EG, Waguespack SG, Jimenez C, et al
    Medullary Thyroid Carcinoma Associated with Germline RET K666N Mutation.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  104. AHN HS, Kim HJ, Kim KH, Lee YS, et al
    Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  105. TOMODA C, Sugino K, Matsuzu K, Uruno T, et al
    Cervical lymph node metastases after thyroidectomy for papillary thyroid carcinoma usually remain stable for years.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  106. GRUBBS EG, Williams MD, Scheet P, Vattathil S, et al
    The role of CDKN2C copy number in sporadic medullary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  107. REN Y, Lence-Anta JJ, Pereda C, Chappa M, et al
    Foxe1 Polymorphism Interacts with Dietary Iodine Intake in Differentiated Thyroid Cancer Risk in the Cuban Population.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  108. PANKRATZ DG, Hu Z, Kim SY, Monroe RJ, et al
    Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  109. ESSIG G JR, Porter K, Schneider DF, Arpaia D, et al
    MULTIFOCALITY IN SPORADIC MEDULLARY THYROID CARCINOMA: AN INTERNATIONAL MULTICENTER STUDY.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  110. SINGER S, Husson O, Tomaszewska IM, Locati L, et al
    Quality of life priorities in patients with thyroid cancer - a multi-national EORTC phase I study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  111. YOUNGWIRTH L, Abdelgadir Adam M, Scheri R, Roman S, et al
    Extrathyroidal Extension is Associated with Compromised Survival in Patients with Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    August 2016
  112. WILTSHIRE JJ, Drake TM, Uttley L, Balasubramanian SP, et al
    Systematic Review of Trends in the Incidence Rates of Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  113. DA FONSECA FL, Yamanaka PK, Kato JM, Matayoshi S, et al
    LACRIMAL SYSTEM OBSTRUCTION AFTER RADIOIODINE THERAPY IN DIFFERENTIATED THYROID CARCINOMAS: A PROSPECTIVE COMPARATIVE STUDY.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  114. IPPOLITO S, Ippolito R, Peirce C, Esposito R, et al
    Recombinant Human Thyroid Stimulating Hormone Improves Endothelial Coronary Flow Reserve in Thyroidectomized Patients With Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  115. SCHEFFEL RS, Zanella AB, Dora JM, Maia AL, et al
    Timing of radioactive iodine administration does not influence outcomes in patients with differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  116. ESPINOSA DE YCAZA AE, Lowe KM, Dean DS, Castro MR, et al
    Risk of Malignancy in Thyroid Nodules with Non-diagnostic Fine Needle Aspiration: A Retrospective Cohort Study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  117. PIRES B, Alves-Junior PA, Bordallo MA, Bulzico DA, et al
    Prognostic factors for early and long-term remission in pediatric differentiated thyroid cancer: the role of gender, age, clinical presentation and the newly proposed American Thyroid Association risk stratification system.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  118. PRAGER G, Koperek O, Mayerhofer M, Muellauer L, et al
    Sustained Response to Vemurafenib in an BRAF V600E-mutated Anaplastic Thyroid Carcinoma Patient.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  119. ONODA N, Sugino K, Higashiyama T, Kammori M, et al
    The safety and efficacy of weekly paclitaxel administration for anaplastic thyroid cancer patients: A nationwide prospective study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  120. LIKHTEROV I, Osorio M, Moubayed SP, Hernandez-Prera J, et al
    The Ethical Implications of the Reclassification of Non Invasive-Follicular Variant Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  121. XU B, Ibrahimpasic T, Wang LY, Sabra M, et al
    Clinico-Pathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  122. NIXON IJ, Simo R, Newbold K, Rinaldo A, et al
    Management of Invasive Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    July 2016
  123. CUI K, Zhang M, Fu C, Ma X, et al
    Comment on "Partially Cystic Thyroid Nodules on Ultrasound: Probability of Malignancy and Sonographic Differentiation".
    Thyroid. 2016.
    PubMed     Text format    


  124. KIM SH, Roh JL, Gong G, Cho KJ, et al
    Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-up.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  125. STRICKLAND KC, Vivero M, Jo VY, Lowe AC, et al
    Pre-operative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): A Prospective Analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  126. ZHANG M, Luo Y, Zhang Y, Tang J, et al
    Efficacy and safety of ultrasound guided radiofrequency ablation for treating low risk papillary thyroid microcarcinoma: a prospective study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  127. LEE DY, Won JK, Choi HS, Park DJ, et al
    Recurrence and survival after gross total removal of resectable undifferentiated or poorly differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  128. OPSAHL EM, Schlichting E, Helset K, Svartberg J, et al
    A Nationwide study of multiple endocrine neoplasia type 2A in Norway. Predictive avd prognostic factors for the clinical course of medullary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  129. RATZON NZ, Uziely B, de Boer AG, Rottenberg Y, et al
    Unemployment risk and decreased income 2 and 4 years after thyroid cancer diagnosis: a population based study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  130. ATALLAH V, Hocquelet A, Do Cao C, Zerdoud S, et al
    Activity and safety of Sunitinib in patients with advanced radio-iodine refractory thyroid carcinoma: a retrospective analysis of 57 patients.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    June 2016
  131. HYUN YG, Alhashemi A, Fazelzad R, Goldberg AS, et al
    A Systematic Review of Unmet Information and Psychosocial Support Needs of Adults Diagnosed with Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  132. MALANDRINO P, Russo M, Regalbuto C, Pellegriti G, et al
    The Outcome Of The Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  133. JENDRZEJEWSKI JP, Liyanarachchi S, Nagy R, Senter L, et al
    Papillary thyroid carcinoma: Association between germline DNA variant markers and clinical parameters.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  134. BERNSTEIN MB, Chang EL, Amini B, Pan H, et al
    SPINE STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH METASTATIC THYROID CANCER - Secondary analysis of Phase I/II trials.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  135. KIM SK, Park I, Woo JW, Lee JH, et al
    Follicular and Diffuse Sclerosing Variant Papillary Thyroid Carcinomas as Independent Predictive Factors of Loco-regional Recurrence: A Comparison Study Using Propensity Score Matching.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  136. VALDERRABANO P, Montilla Soler J, Mifsud MJ, Leon ME, et al
    Hypermetabolism on 18F-FDG PET scan does not influence the interpretation of thyroid cytopathology and nodules with SUVmax <2.5 are not at increased risk for malignancy.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  137. BRITO JP, Bleyer A
    Impact of thyroid cancer on the incidence and survival of adolescents and young adults with cancer.
    Thyroid. 2016.
    PubMed     Text format    


  138. HIRSCH D, Shohat T, Gorshtein A, Robenshtok E, et al
    Incidence of Non-thyroidal Primary Malignancy and the Association with I-131 Treatment in Patients with Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  139. GULEC SA, Kuker RA
    The Clinical Value of I-124 PET/CT Imaging in Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format    


  140. SHRESTHA RT, Evasovich MR, Amin K, Radulescu A, et al
    Correlation between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules - A Two Year Institutional Experience.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  141. WHITE MG, Cipriani NA, Abdulrasool L, Kaplan SP, et al
    Radiation Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease Free Survival.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  142. JINDAL A, Khan U
    Is Thyroglobulin level by LC-MS/MS always reliable for follow-up of DTC after Thyroidectomy: A report of 2 cases.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  143. VALDERRABANO P, Klippenstein DL, Tourtelot JB, Ma Z, et al
    The new ATA sonographic patterns for thyroid nodules perform well in medullary thyroid carcinoma: Institutional experience, systematic review and meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  144. PANI F, Atzori F, Baghino G, Boi F, et al
    HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  145. ANDERSON K, Youngwirth L, Scheri R, Stang M, et al
    T1a vs T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  146. CAMPENNI A, Giovanella L, Siracusa M, Alibrandi A, et al
    99mTc-METHOXY-ISOBUTYL-ISONITRILE (MIBI) SCINTIGRAPHY IS A USEFUL TOOL FOR ASSESSING THE RISK OF MALIGNANCY IN THYROID NODULES WITH INDETERMINATE FINE NEEDLE CYTOLOGY (FNAC).
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  147. SHARMA A, Jasim S, Reading CC, Ristow K, et al
    Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma - A Cohort Study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  148. RUIZ-FERRER M, Fernandez RM, Navarro E, Antinolo G, et al
    The G534E variant in <i>HABP2</i> and Nonmedullary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    May 2016
  149. WONG KS, Angell TE, Strickland KC, Alexander EK, et al
    Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  150. DANIELS GH
    Follicular Variant of Papillary Thyroid Carcinoma: Hybrid or Mixture.
    Thyroid. 2016.
    PubMed     Text format    


  151. KIST JW, de Keizer B, Vogel WV
    Letter to the Editor regarding the article "I-124 PET/CT in patients with differentiated thyroid cancer: clinical and quantitative image analysis".
    Thyroid. 2016.
    PubMed     Text format    


  152. LEE SE, Hwang TS, Choi YL, Han HS, et al
    Prognostic significance of TERT promoter mutations in papillary thyroid carcinomas in a BRAF V600E mutation-prevalent population.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  153. HODAK S, Tuttle RM Md, Maytal G, Nikiforov YE, et al
    Changing the Cancer Diagnosis - the Case of Follicular Variant of Papillary Thyroid Cancer Primum, Non Nocere and NIFTP.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  154. WU JX, Young S, Hung M, Li N, et al
    Clinical Factors Influencing the Performance of Gene Expression Classifier Testing in Indeterminate Thyroid Nodules.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  155. GOLDFARB M, Casillas J
    Thyroid Cancer Specific Quality of Life and Health Related Quality of Life in Young Adult Thyroid Cancer Survivors.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  156. MUJAMMAMI MH, Hier MP, Payne RJ, Rochon L, et al
    Long-term Outcomes of Patients with Papillary Thyroid Cancer undergoing Remnant Ablation with 30 milliCuries Radioiodine.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    April 2016
  157. CAZARIN JM, Coelho RG, Hecht F, Andrade BM, et al
    5 -AMP-activated Protein Kinase (AMPK) Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion and Epithelial-to-Mesenchymal Transition.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  158. LA COUR JL, Andersen UB, Sorensen CH, Nygaard B, et al
    Radioiodine Therapy Does Not Change the Atherosclerotic Burden of the Carotid Arteries.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  159. DU E, Wenig B, Su HK, Rowe ME, et al
    Inter-observer Variation in the Pathologic Identification of Extranodal Extension in Nodal Metastasis from Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  160. HAKALA TT, Kholova I
    Changes in classification of follicular thyroid cancers.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    March 2016
  161. LATROFA F, Ricci D, Sisti E, Piaggi P, et al
    Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  162. JEON M, Chun SM, Kim D, Kwon H, et al
    Genomic alterations of anaplastic thyroid carcinoma detected by targeted massive parallel sequencing in a BRAFV600E mutation-prevalent area.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  163. KIM SK, Woo JW, Park I, Lee JH, et al
    Influence of Body Mass Index and Body Surface Area on the Behavior of Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  164. LEE YH, Seo HS, Suh SI, Ryoo I, et al
    A Feasibility Study of a Contrast-Enhanced Multi-detector CT (64 channels) Protocol for Papillary Thyroid Carcinoma: The Influence of Different Scan Delays on Tumor Conspicuity.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  165. SU HK, Wenig B, Haser GC, Rowe ME, et al
    Inter-observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  166. ARAGON HAN P, Kim HS, Cho S, Fazeli R, et al
    Association of BRAF Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  167. BRITO JP, Kim HJ, Han SJ, Lee YS, et al
    Geographic distribution and evolution of thyroid cancer epidemic in South Korea.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    February 2016
  168. LIN JD, Fu SS, Chen JY, Lee CH, et al
    Clinical Manifestations and Gene Expression in Patients with Conventional Papillary Thyroid Carcinoma Carrying the BRAFV600E Mutation and BRAF Pseudogene.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  169. NIXON IJ, Wang LY, Migliacci JC, Eskander A, et al
    An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  170. URKEN ML, Haser GC, Likhterov I, Wenig B, et al
    The impact of metastatic lymph nodes on risk stratification in differentiated thyroid cancer: Have we reached a higher level of understanding?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  171. KOWALSKA A, Walczyk A, Kowalik A, Palyga I, et al
    Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF Mutation: A Single-Institution Study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  172. SABRA MM, Ghossein R, Tuttle RM
    Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  173. GANDHI A, Wong KK, Gross M, Avram A, et al
    Lingual Thyroid Ectopia: Diagnostic SPECT/CT imaging and Radioactive Iodine Treatment.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  174. BERBER E, Bernet V, Fahey T 3rd, Kebebew E, et al
    American Thyroid Association Statement on Remote Access Thyroid Surgery.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  175. GULEC SA, Kuker RA, Goryawala M, Fernandez C, et al
    I-124 PET/CT IN PATIENTS WITH DIFFERENTIATED THYROID CANCER: CLINICAL AND QUANTITATIVE IMAGE ANALYSIS.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  176. BAKKAR S, Frustaci G, Papini P, Fregoli L, et al
    Track Recurrence After Robotic Transaxillary Thyroidectomy; A Case Report Highlighting The Importance of Controlled Surgical Indications and Addressing Unprecedented Complications.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  177. GRECO A, Albanese S, Auletta L, Mirabelli P, et al
    High-frequency ultrasound-guided injection for the generation of a novel orthotopic mouse model of human thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  178. ROSARIO PW, Carvalho M, Mourao GF, Calsolari MR, et al
    Comparison of antithyroglobulin antibodies concentrations before and after ablation with 131I as predictor of structural disease in differentiated thyroid carcinoma patients with undetectable basal thyroglobulin and negative neck ultrasonography.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  179. BALACHANDAR S, La Quaglia M, Tuttle RM, Heller G, et al
    Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.
    Thyroid. 2016;26:219-26.
    PubMed     Text format     Abstract available


    January 2016
  180. HEATON CM, Chang JL, Orloff LA
    Prognostic implications of lymph node yield in central and lateral neck dissections for well-differentiated papillary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  181. SUH CH, Baek JH, Choi YJ, Lee JH, et al
    Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer: A systematic review and meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  182. KITAHARA CM, McCullough M, Franceschi S, Rinaldi S, et al
    Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  183. ANGELL TE, Lechner MG, Smith AM, Martin SE, et al
    Circulating Myeloid Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  184. NA DG, Baek JH, Sung JY, Kim JH, et al
    Thyroid Imaging Reporting and Data System for Risk Stratification of Thyroid Nodules: Categorization Based on Solidity and Echogenicity.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  185. AHN HY, Chung YJ, Park KY, Cho BY, et al
    Serum 25-Hydroxyvitamin D Level Does Not Affect the Aggressiveness and Prognosis of Papillary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  186. BRITO JP, Ito Y, Miyauchi A, Tuttle RM, et al
    A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
    Thyroid. 2016;26:144-9.
    PubMed     Text format     Abstract available


    December 2015
  187. LEE L, Mitmaker EJ, Chabot JA, Lee JA, et al
    Cost-Effectiveness of Diagnostic Lobectomy Versus Observation for Thyroid Nodules Greater than 4 cm.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  188. ALZAHRANI AS, Qasem E, Murugan AK, Al-Hindi HN, et al
    Uncommon TERT Promoter Mutations in Pediatric Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  189. CASTRONEVES LA, Negrao MV, Freitas RM, Papadia C, et al
    Sorafenib for the treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  190. SAWKA AM, Brierley J, Tsang RW, Rotstein L, et al
    Unmet Information Needs of Low Risk Thyroid Cancer Survivors.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  191. CHEN Y, Sadow PM, Suh H, Lee KE, et al
    BRAFV600E is correlated with recurrence of papillary thyroid microcarcinoma: A systematic review, multi-institutional primary data analysis, and meta-analysis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  192. ITO Y, Miyauchi A, Kudo T, Ota H, et al
    Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  193. SUH CH, Baek JH, Lee JH, Choi YJ, et al
    The role of core-needle biopsy as a first-line diagnostic tool for initially detected thyroid nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  194. BIKAS A, Van Nostrand D, Jensen KE, Desale S, et al
    Metformin Attenuates <sup>131</sup>I - Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  195. NIKITA ME, Jiang W, Cheng SM, Hantash FM, et al
    Mutational analysis in Pediatric Thyroid Cancer and correlations with age, ethnicity and clinical presentation.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    November 2015
  196. PITOIA F, Miyauchi A
    2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer and their Implementation in Various Care Settings.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  197. KIM JW, Roh JL, Gong G, Cho KJ, et al
    Treatment Outcomes and Risk Factors for Recurrence after Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  198. ESPIARD S, Petyt G, Lion G, Beron A, et al
    Ectopic Subcutaneous Implantation of Thyroid Tissue after Gasless Transaxillary Robotic Thyroidectomy for Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  199. JEON M, Kim WG, Choi YM, Kwon H, et al
    Features predictive of distant metastasis in papillary thyroid microcarcinoma.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  200. LIU X, Medici M, Kwong N, Angell TE, et al
    Bethesda Categorization of Thyroid Nodule Cytology & Prediction of Thyroid Cancer Type and Prognosis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  201. BERNARDI S, Lanzilotti V, Papa G, Panizzo N, et al
    Full-thickness skin burn caused by radiofrequency ablation of a benign thyroid nodule.
    Thyroid. 2015.
    PubMed     Text format    


  202. DE NAPOLI L, Bakkar S, Ambrosini CE, Materazzi G, et al
    Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    October 2015
  203. HAUGEN BR MD, Alexander EK, Bible KC, Doherty G, et al
    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  204. COURA-FILHO GB, Carvalho JW, Buchpiguel CA, Sapienza MT, et al
    Effects of thyroid hormone withdrawal and recombinant human TSH on glomerular filtration rate during radioiodine therapy for well-differentiated thyroid cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  205. AN JH, Yul H, Ahn HY, Keam B, et al
    A Possible Association Between Thyroid Cancer and Breast Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  206. CHOI YJ, Baek JH, Baek S, Shim WH, et al
    Web-based Malignancy Risk Estimation for Thyroid Nodules using Ultrasonography Characteristics: Development and Validation of a Predictive Model.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  207. KHOKHAR MT, Day KM, Sangal RB, Ahmedli NM, et al
    Preoperative High-Resolution Ultrasound for the Assessment of Malignant Central Compartment Lymph Nodes In Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  208. ASCHEBROOK-KILFOY B, James BC, Nagar S, Kaplan S, et al
    Risk Factors for Decreased Quality of Life in Thyroid Cancer Survivors: Initial Findings from the North American Thyroid Cancer Survivorship Study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  209. PATEL DT, Kitahara CM, Park Y, Liao LM, et al
    Thyroid Cancer and Nonsteroidal Antiinflammatory Drug Use: A Pooled Analysis of Patients Over 40 years of Age.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  210. ODA H, Miyauchi A, Ito Y, Yoshioka K, et al
    Incidences of Unfavorable Events in the Management of Low-risk Papillary Microcarcinoma of the Thyroid by Active Surveillance vs. Immediate Surgery.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    September 2015
  211. FAN N, Talaga M, Brown R, Fueri A, et al
    Glycan-dependent mutual and reversible sequestration of two thyroid cancer biomarkers.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  212. COYNE C, Afkhami M, Karunamurthy A, Chiosea SI, et al
    Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF K601E Mutation.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  213. ARAGON HAN P, Weng CH, Khawaja HT, Nagarajan N, et al
    MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  214. DANILOVIC DL, de Camargo RY, Castro G Jr, Papadia C, et al
    Rapid Control of T3 Thyrotoxicosis in Patients with Metastatic Follicular Thyroid Cancer Treated with Lenvatinib.
    Thyroid. 2015.
    PubMed     Text format    


  215. ATKINS F, Van Nostrand D, Moreau S, Burman K, et al
    Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of I.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  216. FERRIS RL, Carty SE
    Response to Letter to the Editor on COI for American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format    


  217. NIKIFOROV YE, Carty SE, Chiosea SI, Coyne C, et al
    Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  218. SHRESTHA RT, Karunamurthy A, Amin K, Nikiforov YE, et al
    Multiple Mutations Detected Preoperatively May Predict Aggressive Behavior of Papillary Thyroid Cancer and Guide Management - A Case Report.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  219. KLOOS RT, Kennedy GC
    Response to "American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making".
    Thyroid. 2015.
    PubMed     Text format    


  220. KIM D, Hwang SH, Cha J, Jo K, et al
    Risk Stratification of Thyroid Incidentalomas Found on PET/CT: The Value of Iodine Content on Noncontrast Computed Tomography.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    August 2015
  221. TOLEDO RA, Maciel RM, Erlic Z, Lourenco DM Jr, et al
    RET Y791F Variant Does Not Increase the Risk for Medullary Thyroid Carcinoma.
    Thyroid. 2015;25:973-4.
    PubMed     Text format    


    July 2015
  222. MCLEOD DS, Jonklaas J, Brierley J, Ain KB, et al
    Reassessing the NTCTCS staging systems for differentiated thyroid cancer, including age at diagnosis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  223. DADU R, Hu MI, Cleeland CS, Busaidy N, et al
    The efficacy of the natural clay, Calcium Aluminosilicate Anti-Diarrheal (CASAD), in reducing medullary thyroid cancer-related diarrhea and its effects on quality of life: a pilot study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  224. SINGH OSPINA NM, Sebo TJ, Morris JC 3rd, Castro MR, et al
    The value of repeat thyroid fine needle aspiration biopsy in patients with a previously benign result: How often does it alter management?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  225. AL AFIF A, Williams BA, Rigby MH, Bullock M, et al
    Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  226. GANLY I, Nixon IJ, Wang LY, Palmer FL, et al
    Survival from differentiated thyroid cancer What has age got to do with it?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  227. ROSARIO PW, Calsolari MR
    What is the best criterion for repetition of fine-needle aspiration in thyroid nodules with initially benign cytology?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  228. DE BIASE D, Gandolfi G, Ragazzi M, Eszlinger M, et al
    TERT PROMOTER MUTATIONS IN THYROID PAPILLARY MICROCARCINOMAS.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  229. SEO GH, Cho YY, Chung JH, Kim SW, et al
    Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  230. WIEBEL JL, Esfandiari NH, Papaleontiou M, Worden FP, et al
    Evaluating Positron Emission Tomography Use in Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  231. VACCARELLA S, Dal Maso L, Laversanne M, Bray F, et al
    The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  232. LARRIVEE-VANIER S, Magne F, Patey N, Chanoine JP, et al
    Conserved telomere length in human ectopic thyroids: an argument against premature differentiation causing arrested migration.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  233. PITOIA F, Jerkovich F, Urciuoli C, Schmidt A, et al
    Implementing the Modified 2009 American Thyroid Association Risk Stratification System in thyroid cancer patients with low and intermediate risk of recurrence.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  234. RALHAN R, Veyhl J, Chaker S, Assi J, et al
    Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine Needle Aspiration Biopsy Clinical Application.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    June 2015
  235. WANG LY, Ghossein R Md, Palmer FL, Nixon IJ, et al
    Microscopic Positive Margins in differentiated thyroid cancer is not an independent predictor of local failure.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  236. BRITO JP, AlNofal A, Montori V, Hay ID, et al
    The impact of subclinical disease and mechanism of detection on the rise in thyroid cancer incidence: a population-based study in Olmsted County, Minnesota during 1935 through 2012.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    May 2015
  237. HINSON AM, Kandil E, O'Brien S, Spencer HJ, et al
    Trends in Robotic Thyroid Surgery in the United States from 2009 through 2013.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  238. DEANDREA M, Sung JY, Limone PP, Mormile A, et al
    Efficacy and Safety of Radiofrequency Ablation versus Control Condition for Nonfunctioning Benign Thyroid Nodules: A Randomized Controlled International Collaborative Trial.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  239. FERRIS RL, Baloch ZW, Bernet V, Chen A, et al
    American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: current impact on perioperative decision-making.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  240. CHOI SH, Baek JH, Lee JH, Choi YJ, et al
    Evaluation of the clinical usefulness of BRAFV600E mutation analysis of core-needle biopsy specimens in thyroid nodules with previous atypia of undetermined significance (AUS) or follicular lesions of undetermined significance (FLUS) results.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  241. MARTI JL, Davies L, Haymart MR, Roman BR, et al
    Inappropriate use of radioactive iodine for low-risk papillary thyroid cancer is most common in regions with poor access to health care.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  242. BRAUNER E, Holmes BJ, Krane J, Nishino M, et al
    Performance of the Afirma Gene Expression Classifier in Hurthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  243. MOND M, Bullock M, Yao Y, Clifton-Bligh RJ, et al
    Somatic Mutations of FOXE1 in Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  244. HANLEY JP, Jackson E, Morrissey LA, Rizzo DM, et al
    Geospatial and Temporal Analysis of Thyroid Cancer Incidence in a Rural Population.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    April 2015
  245. KIM SM, Kim HK, Chang H, Kim KJ, et al
    Recovery from Permanent Hypoparathyroidism after Total Thyroidectomy.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  246. FRANCIS G, Waguespack SG, Bauer AJ, Angelos P, et al
    Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Pediatric Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  247. NAKAMURA H, Hirokawa M, Ota H, Kihara M, et al
    Is an increase in thyroid nodule volume a risk factor for malignancy?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  248. MARTI JL, Jain KS, Morris LG
    Increased risks of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  249. YI KS, Kim JH, Na DG, Seo H, et al
    Usefulness of Core Needle Biopsy for Thyroid Nodules with Macrocalcifications: Comparison with Fine Needle Aspiration.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  250. WEISS RJ, Magner J
    Serial Measurements of Serum Thyroglobulin in Response to Recombinant Human Thyrotropin (rhTSH) Stimulation.
    Thyroid. 2015.
    PubMed     Text format    


  251. WU JX, Beni CE, Zanocco K, Sturgeon C, et al
    Cost-Effectiveness of Long-Term Every Three-Year Versus Annual Postoperative Surveillance for Low Risk Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    March 2015
  252. MORLEY S, Goldfarb M
    Support Needs and Survivorship Concerns of Thyroid Cancer Patients.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  253. RANDOLPH G, Sritharan N, Song P, Franco R, et al
    Thyroidectomy in the Professional Singer-Neural Monitored Surgical Outcomes.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  254. KEEGAN T, Grogan R, Parsons H, Tao L, et al
    Socio-demographic disparities in differentiated thyroid cancer survival among adolescents and young adults in California.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  255. KLOPPER J, Kane MA, Jimeno A, Sams S, et al
    A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  256. HOANG JK, Langer JE, Middleton WD, Wu CC, et al
    Misinterpretation of the American College of Radiology White Paper on Managing Incidental Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format    


  257. ROSARIO PW, Mourao GF, Siman TL, Calsolari MR, et al
    Serum thyroglobulin measured with a second-generation assay in patients undergoing total thyroidectomy without radioiodine remnant ablation: A prospective study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  258. REMONTI LR, Kramer CK, Leitao CB, Pinto LC, et al
    Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  259. SEMRAD T, Semrad A, Farwell DG, Chen Y, et al
    Initial Treatment Patterns in Younger Adult Patients with Differentiated Thyroid Cancer in California.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  260. MEDAPATI MR, Dahlmann M, Ghavami S, Pathak KA, et al
    RAGE mediates the pro-migratory response of extracellular S100A4 in human thyroid cancer cells.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    February 2015
  261. HAYASE S, Sasaki Y, Matsubara T, Seo D, et al
    Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  262. PERTICONE F, Pigliaru F, Mariotti S, Deiana L, et al
    IS THE INCIDENCE OF DIFFERENTIATED THYROID CANCER INCREASED IN PATIENTS WITH TSH-SECRETING ADENOMA? REPORT OF THREE CASES FROM A LARGE CONSECUTIVE SERIES OF TSH-OMA.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    January 2015
  263. NASCIMENTO C, Borget I, Al Ghuzlan A, Deandreis D, et al
    Post-operative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT): an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  264. CHAMI L, Hartl DM, Leboulleux S, Baudin E, et al
    PREOPERATIVE LOCALIZATION OF NECK RECURRENCES FROM THYROID CANCER: CHARCOAL TATTOOING UNDER ULTRASOUND GUIDANCE.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  265. CHOUGNET CN, Borget I, Leboulleux S, de la Fouchardiere C, et al
    Vandetanib for the treatment of advanced medullary thyroid cancer outside a trial: results from a French cohort.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  266. BURYK MA, Simons JP, Picarsic JL, Monaco SE, et al
    Can malignant thyroid nodules be distinguished from benign thyroid nodules in children and adolescents by clinical characteristics? A review of 89 pediatric patients with thyroid nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  267. TUFANO R, Noureldine SI, Angelos P
    Ethical Responsibilities of Caring for Patients with Incidental Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  268. FENG X, Milas M, O'Malley M, LaGuardia L, et al
    Characteristics of Benign and Malignant Thyroid Disease in Familial Adenomatous Polyposis Patients and Recommendations for Disease Surveillance.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  269. LYLE M, Dean D
    Ultrasound Guided Fine Needle Aspiration Biopsy of Thyroid Nodules in Patients taking Novel Oral Anticoagulants.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  270. SACKS W, Wong R, Bresee C, Braunstein G, et al
    Use of Evidence-Based Guidelines Reduces I131 Treatment in Patients with Low Risk Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  271. ROGOUNOVITCH T, Bychkov A, Takahashi M, Mitsutake N, et al
    The common genetic variant rs944289 at chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in Japanese population.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    December 2014
  272. BEUTNER U, Leowardi C, Bork U, Luthi C, et al
    Survival after renal cell carcinoma metastasis to the thyroid. Single center experience and systematic review of the literature.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


    November 2014
  273. NAGARAJAN N, Schneider EB, Ali SZ, Zeiger MA Md, et al
    How Do Liquid Based Preparations of Thyroid FNA Compare with Conventional Smears? An Analysis of 5475 Specimens.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: